Results 1 to 10 of about 4,971 (146)

[Current therapeutic possibilities with tricyclic antidepressive agents].

Der Nervenarzt, 1997
openaire   +1 more source

[Neurological and cardiovascular complications of poisoning by tricyclic antidepressive agents].

Revista espanola de anestesiologia y reanimacion, 1981
J M, Martínez-Forde, V, Cerdeño, F, Mariscal Sistiaga, A, Aguado Matorras   +3 more
openaire   +1 more source

[Poisoning caused by tricyclic antidepressive agents and its therapy].

Zeitschrift fur arztliche Fortbildung, 1983
R, Sütterlin, W, Fritzsch
openaire   +1 more source

Combined intoxication with tricyclic antidepressive and neuroleptic agents

1995
Poelmans, Luc, Diltoer, M., Spapen, Herbert, Hubloue, Ives, Maes, Viviane, Huyghens, Luc   +5 more
openaire   +1 more source

[Poisonings with tricyclic antidepressive agents and phenothiazines and their therapy with physostigmine].

Anaesthesiologie und Reanimation, 1986
E, Prenzel, G, Krohs
openaire   +1 more source

[Tricyclic antidepressive agents. Principles and rules for their use].

La Revue du praticien, 1993
openaire   +1 more source

[Criteria of evaluation of tricyclic antidepressive agents in humans].

Therapie, 1974
openaire   +1 more source

The Brugada Type 1 Electrocardiogram and Ventricular Tachycardia With High-Dose Amitriptyline

JACC: Case Reports, 2021
A 32-year-old woman with anorexia nervosa experienced ventricular tachycardia while on therapeutic-dose amitriptyline despite normal blood tests, imaging, and intracardiac recordings.
Ji-Jian Chow, MRCP, Nandita Kaza, MBChB, Amanda Varnava, MD   +2 more
doaj   +1 more source

Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study

Frontiers in Pharmacology, 2020
Aims: Conflicting data exist on whether an association exists between antidepressants and the risk of major adverse cardiovascular events (MACEs) in patients with depression.
Ha Young Jang, Jae Hyun Kim, Yun-Kyoung Song, Yun-Kyoung Song, Ju-Young Shin, Hae-Young Lee, Yong Min Ahn, Jung Mi Oh, In-Wha Kim   +8 more
doaj   +1 more source

Ferulic acid as a therapeutic agent in depression: Evidence from preclinical studies

CNS Neuroscience &Therapeutics, Volume 29, Issue 9, Page 2397-2412, September 2023., 2023
Abstract Depression is a common but severe mood disorder with a very high prevalence across the general population. Depression is of global concern and poses a threat to human physical and mental health. Ferulic acid (FA) is a natural active ingredient that has antioxidative, anti‐inflammatory, and free radical scavenging properties.
Xiaoyu Dong, Dongxue Zhao
wiley   +1 more source